PEBP1 and cervical cancer: In general, we found that RKIP is highly expressed at the cytoplasm in the benign lesions (54% of the samples; 73/135), but is significantly (p<0.05) reduced in cervical cancer (independently of the histological subtype), with only ∼15% (19/124) of the samples staining positively.